🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
Recordati Industria Chimica e Farmaceutica SPA 
Pharma / Pharmaceuticals and Healthcare
At a Glance | Core Facts | Company Due Diligence: | Industry Due Diligence: | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | Web1. Competition Risk: Recordati Industria Chimica e Farmaceutica SPA faces competition from other pharmaceutical companies, both domestic and international. This could lead to decreased sales and profits.
2. Regulatory Risk: Recordati Industria Chimica e Farmaceutica SPA is subject to stringent regulations. It must adhere to stringent regulations for the manufacture, distribution and sale of its products. Changes to these regulations could adversely affect its sales and profits.
3. Investment Risk: Recordati Industria Chimica e Farmaceutica SPA has to invest heavily in technology and research and development to stay competitive. Failure to do so could lead to decreased sales.
4. Economic Risk: Recordati Industria Chimica e Farmaceutica SPA faces economic risk due to fluctuations in economic growth. If the economy slows down, its sales and profits could be adversely affected.
Wait! There's more — sign up for free or log in